Please assess the completion status of the following clinical trial:

Trial Title: Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria :~- Patient over 18 years of age~* Current alcohol consumption (several times a month)~* Compliance with the criteria for harmful use or dependence according to AUDIT scale greater than or equal to 7 for men or 6 for women~* Outpatient follow-up in primary care or in addictology in the addictology network of northern Finistère~Exclusion Criteria :~* Patient under 18 years of age~* Subject under legal protection, guardianship, or curatorship or deprived of liberty~* Non comprehension of the French language~* Acute unstable psychiatric disorders affecting judgment~* No fixed or cell phone line~* AUDIT score less than 6 for women and 7 for men~* Addictology hospitalization history in the last 12 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Motivational interview (Type: EXPERIMENTAL): Patients followed in the primary care network participating in the study and those followed in the addictology network of northern Finistère in the context of their pathology will be offered the opportunity to participate in the study.~If the patient was randomized to the intervention group, the patient will receive 2 individual sessions (motivational interview) by telephone within 1 month of inclusion. They will then be assessed at month 1, month 3 and month 6. These assessments will be done by telephone.
- Routine Care (Type: ACTIVE_COMPARATOR): Patients followed in the primary care network participating in the study and those followed in the addictology network of northern Finistère in the context of their pathology will be offered the opportunity to participate in the study.~If the patient has been randomized to the control group, the patient will be assessed at month 1, month 3 and month 6. These assessments will be done by telephone.

Based on this trial design, predict the completion outcome and termination type (if applicable).